Business Description
Description
Odontoprev SA provides dental benefit plans throughout Brazil and operates a sizable network of dentists throughout the country. The firm operates in three segments based on client size as well as one auxiliary segment that includes dental care goods and services. The dental care plan segments include corporate plans with many contracts (more than 200); small and midsize, with smaller groups of contracts; and individual, which includes monthly and annual plans sold directly to individuals. The majority of Odontoprev's revenue is generated by the corporate segment.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.75 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.38 | |||||
| Beneish M-Score | -3.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.4 | |||||
| 3-Year EBITDA Growth Rate | 13.6 | |||||
| 3-Year EPS without NRI Growth Rate | 10.5 | |||||
| 3-Year FCF Growth Rate | 39.5 | |||||
| 3-Year Book Growth Rate | 3.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | |||||
| Quick Ratio | 0.73 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 1.99 | |||||
| Days Sales Outstanding | 31.58 | |||||
| Days Payable | 9.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 18.9 | |||||
| 3-Year Average Share Buyback Ratio | 0.8 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.51 | |||||
| Operating Margin % | 29.87 | |||||
| Net Margin % | 24.06 | |||||
| ROE % | 39.06 | |||||
| ROA % | 22.5 | |||||
| ROIC % | 20.84 | |||||
| ROC (Joel Greenblatt) % | 970.29 | |||||
| ROCE % | 46.49 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.99 | |||||
| Forward PE Ratio | 14.25 | |||||
| PE Ratio without NRI | 11.99 | |||||
| Shiller PE Ratio | 13.81 | |||||
| Price-to-Owner-Earnings | 8.13 | |||||
| PEG Ratio | 1.04 | |||||
| PS Ratio | 2.86 | |||||
| PB Ratio | 4.35 | |||||
| Price-to-Tangible-Book | 14.59 | |||||
| Price-to-Free-Cash-Flow | 7.35 | |||||
| Price-to-Operating-Cash-Flow | 6.72 | |||||
| EV-to-EBIT | 7.81 | |||||
| EV-to-EBITDA | 7.08 | |||||
| EV-to-Revenue | 2.61 | |||||
| EV-to-FCF | 6.77 | |||||
| Price-to-Projected-FCF | 0.87 | |||||
| Price-to-DCF (FCF Based) | 0.37 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.36 | |||||
| Earnings Yield (Greenblatt) % | 12.8 | |||||
| Forward Rate of Return (Yacktman) % | 13.45 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:ODPVF
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 354.435 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.94 - 10 | ||
| Shares Outstanding (Mil) | 520.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Odontoprev SA Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Odontoprev SA Analysis
Share your researchHeadlines
See More
No news.